Acknowledgement

We thank the ITOC4 Scientific Committee:

Conference Presidents

  • Christoph Zielinski (Medical University of Vienna, Austria)
  • Howard L. Kaufman (Rutgers Cancer Institute of New Jersey, USA)

Chairman of the Scientific Committee

  • Heinz Zwierzina (Innsbruck University, Austria)

Scientific Committee

  • Paolo A. Ascierto (Istituto Nazionale Tumori, Italy)
  • Lisa H. Butterfield (University of Pittsburgh, USA)
  • Bernard A. Fox (Providence Cancer Center, USA)
  • Leif G. Hakansson (Universitetssjukhuset Linköping, Sweden)
  • Robert F. Hawkins (The Christie Hospital, United Kingdom)
  • Samir N. Khleif (Georgia Regents University, United States)
  • Sebastian Kobold (Ludwig-Maximilians-Universität, Germany)
  • Zihai Li (Medical University of South Carolina, USA)
  • Volkmar Nuessler (Munich Tumour Center, Germany)
  • Lubos Petruzelka (Charles University, Czech Republic)
  • Jose Saro (Roche, Switzerland)
  • Barbara Seliger (Martin Luther University Halle-Wittenberg, Germany)
  • Mario Sznol (Yale School of Medicine, USA)
  • Wenru Song (Chinese American Hematology and Oncology Network, USA)
  • Eric Tartour (Hôpital Européen Georges-Pompidou, France)
  • Rostislav Vyzula (Masaryk Memorial Cancer Institute, Czech Republic)
  • Zhen Su (Merck KGaA, Germany)

We thank all ITOC4 sponsors and partners.

The ITOC4 Organising Committee wishes to gratefully acknowledge our sponsors and exhibitors for supporting the 4th Immunotherapy of Cancer Conference (ITOC4).

Sponsors

1.

bms301 Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our medicines are helping millions of people around the world in their fight against cancer, cardiovascular disease, hepatitis C, HIV and rheumatoid arthritis.

View more on www.bms.com

2.

 Incyte_2CPos_RGB Incyte Corporation

Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. World-class science and the pursuit of R&D excellence drive Incyte’s business and its commitment to improving the lives of patients with cancer and other diseases. Incyte has a broad and diverse clinical portfolio that includes 14 development candidates against 11 different molecular targets.

View more on www.incyte.com

3.

www.lillyoncology.com/ Lilly Oncology

For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world. To learn more about Lilly’s commitment to people with cancer, please visit www.LillyOncology.com.

4.

_Miltenyi Biotech_Logo Miltenyi Biotec

Miltenyi Biotec provides products that advance biomedical research and cellular therapy. Our innovative tools support research from basic research to translational research to clinical application. Our more than 25 years of expertise includes immunology, stem cell biology, neuroscience, and cancer. Miltenyi Biotec has more than 1,700 employees in 25 countries.

View more on www.miltenyibiotec.com

 5.

msd_3282 MSD

For over a century, MSD has been a global health care leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., Kenilworth, N.J., USA. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.msd.com or www.msd.XX (for country-specific website).

6.

logo_nanostring NanoString Technologies

NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company’s nCounter® Analysis System, which has been employed in basic and translational research and cited in 1,000+ peer review publications, has also now been applied to diagnostic use with the nCounter Dx Analysis System. The nCounter-based Prosigna™ Breast Cancer Prognostic Gene Signature Assay is marketed for use on the nCounter Dx Analysis System which is FDA 510(k) cleared.

View more on www.nanostring.com

7.

thermo fisher scientific Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.

For more information, please visit www.thermofisher.com

Exhibitors

1.

 Acris-is-now-OriGene-Europe Acris Antibodies

Acris Antibodies acquired by OriGene recently, offer > 1 million research products – everything you need for gene and protein based research: cDNA clones, siRNA, lysates, proteins, antibodies and many more. Acris Antibodies-OriGene EU  is your “1 stop solution provider”. We support you as cancer research scientists in your gene as well as protein directed approaches.

View more on https://www.acris-antibodies.com

2.

 aquilaA4-black04[1] Aquila BioMedical

Aquila BioMedical is an innovative, preclinical contract research organisation, offering clients world-leading research expertise in immuno-oncology, immunology and multiplex histology. We offer bespoke services, combining advanced models with protocolled techniques. The result? High-value data allowing you to define efficacy and mechanism of action of drug/antibody candidates. Partner with us to benefit from expert advice and data interpretation from superior and experienced scientists.

 View more on http://www.aquila-bm.com

3.

biolegend_enabling_large BioLegend

BioLegend develops and manufactures world-class, cutting-edge antibodies and reagents at an outstanding value. The broad product portfolio includes flow cytometry, cell biology, and functional reagents for research in immunology, neuroscience, cancer, and stem cells. Custom services include assay development, sample testing, and conjugation. BioLegend is certified for ISO 9001:2008 and ISO 13485:2003.

View more on www.biolegend.com

4.

 CDDF LOGO The Cancer Drug Development Forum (CDDF)

CDDF looks forward to welcoming you at the 4th edition of the Immunotherapy of Cancer Conference (ITOC4) in Prague. We will be available to meet you at the exhibition area, feel free to come and visit us at any time!

The (CDDF) is an international organization providing a platform for all stakeholders involved in the development of oncology drugs. The aim of the not-for-profit organization is to accelerate the delivery of effective oncology agents to patients.

View more on http://cddf.org/ ; https://twitter.com/cddf_eu

5.

 Final CrownBio logo Crown BioScience

Crown Bioscience, Inc. is a platform technology company providing drug discovery and development services in Oncology and Metabolic Disease.

Our unique collection of ready-to-run, well-validated in vitro, in vivo, ex vivo models, comprehensive Translational Platform, and immunotherapy models including syngeneic and humanized systems, enable clients to deliver superior clinical candidates.

View more on https://www.crownbio.com/

6.

DiscoverXLogo DiscoverX

DiscoverX Corporation is the leading supplier of innovative cell-based assays and services for drug discovery and development. The industry-leading portfolio of products and services, under the KINOMEscan®, PathHunter® and BioMAP® brands, enables rapid development of safe and effective biologic and small molecule drugs from early discovery through preclinical development.

View more on www.discoverx.com

7.

 Incyte_2CPos_RGB Incyte Corporation

Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. World-class science and the pursuit of R&D excellence drive Incyte’s business and its commitment to improving the lives of patients with cancer and other diseases. Incyte has a broad and diverse clinical portfolio that includes 14 development candidates against 11 different molecular targets.

View more on www.incyte.com

8.

Immudex Monitoring Immudex

Based in Copenhagen, Denmark, Immudex manufactures MHC Dextramers for the detection of antigen-specific T cells in life science research, in vitro diagnostics, and the development of immunotherapeutics and vaccines.  Under an agreement with the US Cancer Immunotherapy Consortium (CIC) and the European Cancer Immunotherapy Consortium (CIMT), Immudex also provides MHC Multimer and Elispot proficiency panel services worldwide.

View more on : www.immudex.com

9.

 New MBL logo CMYK MBL International

MBL International is a life science company focused on providing high quality, innovative, solutions-based products for life science research and clinical diagnostics. MBLI develops and manufactures a broad portfolio of monoclonal and polyclonal antibodies, MHC tetramers, fluorescent and recombinant proteins and ELISA kits for research related to allergy, apoptosis, autophagy, cancer, epigenetics, immunology, and neuroscience.

View more on https://www.mblintl.com/

10.

MerckPfizer Logo Merck-Pfizer Alliance 

Immuno-oncology is a top priority for Merck and Pfizer. The global strategic alliance between Merck and Pfizer enables the companies to benefit from each other’s strengths and capabilities and further explore the therapeutic potential of avelumab, an investigational anti-PD-L1 antibody initially discovered and developed by Merck. The immuno-oncology alliance will jointly develop and commercialize avelumab and advance Pfizer’s PD-1 antibody.

View more on http://www.merckgroup.com

11.

logo_nanostring NanoString Technologies

NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company’s nCounter® Analysis System, which has been employed in basic and translational research and cited in 1,000+ peer review publications, has also now been applied to diagnostic use with the nCounter Dx Analysis System. The nCounter-based Prosigna™ Breast Cancer Prognostic Gene Signature Assay is marketed for use on the nCounter Dx Analysis System which is FDA 510(k) cleared.

View more on www.nanostring.com

12.

PeproTech-logo PeproTech

PeproTech is a privately owned biotechnology company focusing on the development and manufacture of high quality cytokine products for the life-science and cell therapy market. With over 2,000 products PeproTech has developed and refined innovative protocols to ensure quality, reliability and consistency. We pride ourselves on being a trusted partner within the scientific community. Please contact: 020 7610 3062 or info@peprotech.co.uk

View more on https://www.peprotech.com/en-GB

13.

 SITC logo  The Society for Immunotherapy of Cancer (SITC)

SITC is a 501 (c)(3) non-profit professional society of over 1,600 influential scientists and practitioners from around the world who are dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Through emphasis on high-caliber scientific meetings, education, and collaborations , SITC brings together all aspects of cancer immunology and immunotherapy.

View more on www.sitcancer.org ; https://twitter.com/sitcancer

14.

thermo fisher scientific Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.

For more information, please visit www.thermofisher.com

Partners

1.

Cahon Logo  The Chinese American Hematologist and Oncologist Network (CAHON)

For more information, please visit http://cahon.org/

2.

SITC logo The Society for Immuntherapy of Cancer (SITC)

For more information, please visit http://www.sitcancer.org/

3.

Munich tumour Centre 21-12-2016 Tumorzentrum München – TZM (Munich Tumour Centre)

For more information, please visit http://www.tumorzentrum-muenchen.com/

 

-.